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OBJECTIVES We sought to validate the recently proposed Mayo Clinic risk score model for complications
after percutaneous coronary interventions (PCI), using an independent data set.
BACKGROUND The Mayo Clinic risk score has eight simple clinical and angiographic variables for the
prediction of complications defined as either death, Q-wave myocardial infarction, emergent
or urgent coronary artery bypass graft surgery, or cerebrovascular accident after PCI. External
validation using an independent data set is lacking.
METHODS A total of 3,264 patients undergoing PCI at each of the 17 sites in the National Heart, Lung,
and Blood Institute’s Dynamic Registry during two enrollment periods (July 1997 to February
1998 and February to June 1999) were studied. Logistic regression was used to model the
calculated risk score and major procedural complications. The expected number of compli-
cations, with 95% confidence bounds (CBs), was also calculated.
RESULTS There were 96 (2.94%) observed procedural complications, and the Mayo Clinic risk score
predicted 93.5 events (2.86%; 95% CB 2.32% to 3.41%; p  NS). The Hosmer-Lemeshow
goodness-of-fit p value was 0.28, and the area under the receiver operating curve was 0.76,
indicating excellent overall discrimination. There were no statistical differences between
observed and predicted procedural complications using the Mayo Clinic risk score among the
most selected high- and low-risk subgroups.
CONCLUSIONS Eight variables were combined into a convenient risk scoring system that accurately predicts
cardiovascular complications after PCI. The Mayo clinic predictive model for procedural
complications yielded excellent results when applied to a multi-center external data
set. (J Am Coll Cardiol 2003;42:1722–8) © 2003 by the American College of Cardiology
Foundation
With increasing operator experience, refinement in technol-
ogy, and the availability of improved stent designs, percu-
taneous coronary intervention (PCI) is now considered the
treatment of choice for many high-risk subgroups in which
PCI was previously contraindicated (1–3). Current risk
adjustment models for PCI have been restricted to
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procedural mortality, thereby ignoring other important
complications that can significantly increase morbidity and
the length of hospital stay (4–8). Using Mayo Clinic data
on patients undergoing PCI, we published a procedural
complications risk score model that included not only death
but also Q-wave myocardial infarction (MI), emergent or
urgent coronary artery bypass graft surgery (CABG), and
cerebrovascular accident (9). This internally validated
model, comprised of eight clinical and angiographic vari-
ables, however, lacked external validation. The multi-center
National Heart, Lung, and Blood Institute’s (NHLBI)
Dynamic Registry was designed to obtain periodic updates
of the practice of interventional cardiology, with emphasis
on patient and lesion selection criteria, procedural perfor-
mance, and early and intermediate-term outcomes. Given
the similarities in data collection and definitions between
the Mayo Clinic and Dynamic Registry, we sought to
validate the Mayo Clinic risk score for procedural compli-
cations after PCI, using the NHLBI Dynamic Registry
data set.
METHODS
Mayo Clinic risk score. Briefly, the Mayo Clinic proce-
dural complications risk score was comprised of the follow-
ing eight clinical and angiographic variables: age, cardio-
genic shock, serum creatinine 264 mol/l, urgent or
emergent procedure, New York Heart Association (NYHA)
functional class III heart failure, thrombus, and left main
and multi-vessel disease (Table 1). The risk score was based
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on 5,463 patients’ data collected between January 1, 1996,
and December 31, 1999 (9).
Study population. The NHLBI Dynamic Registry is a
prospective cohort study of consecutive patients treated with
PCI at participating clinical sites across the U.S. and
Canada. The registry enrolls and follows patients in “waves.”
The first wave of the registry enrolled 2,524 patients from
15 clinical sites between July 1997 and February 1998, and
the second wave enrolled 2,105 patients from 16 clinical
sites between February and June 1999. This report com-
bines data from waves 1 and 2 because of the absence of
differences in the clinical characteristics of patients in both
waves (10). The present analysis was confined to 3,264 of
these patients. Patients excluded from this analysis were
those whose age at baseline was unknown (n  9), those
who reported a previous PCI (n  1,343), and those who
needed elective CABG during the index hospitalization for
severe residual disease (n  14). The latter two exclusions
were stipulations made by the Mayo Clinic risk score
analysis. Each clinical center received approval from its
Institutional Review Board.
Definitions. The outcome for this analysis was the inci-
dence of major procedural complications, defined as one or
more of the following: 1) in-hospital death; 2) Q-wave MI;
3) urgent or emergent CABG; and 4) cerebrovascular
accident during the index hospital admission.
The definitions used by the Dynamic Registry are similar
to those used in the original Mayo Clinic risk score for
in-hospital death, Q-wave MI, CABG, and cerebrovascular
accidents. Current physician-diagnosed congestive heart
failure (CHF) during index hospitalization was used in
place of the NYHA classification for congestive heart failure
that was used by the Mayo Clinic risk score. In addition, a
history of chronic kidney disease or end-stage renal disease
was used in place of high serum creatinine because creati-
nine values were not routinely collected. Lastly, there are
differences in the definition of “vessel disease,” with the
Dynamic Registry using 50% diameter stenosis and the
Mayo Clinic using 70%. Detailed baseline patient demo-
graphic, angiographic, and procedural variables have been
described in the original Mayo Clinic risk score report (9)
and in previous Dynamic Registry publications (10,11).
Statistical methods. Crude incidence rates of major in-
hospital complications were calculated for baseline demo-
graphic, procedural, and angiographic characteristics and
compared using the Pearson chi-square test. Similarly, odds
ratios and standard 95% confidence intervals were calculated
using the Mantel-Haenszel method. Risk scores using the
Mayo Clinic risk score model were calculated from coeffi-
cients derived from the multivariable risk factor equation for
major procedural complications associated with coronary
intervention procedures (9). The probabilities of procedural
complications were then summed to determine an expected
number of in-hospital complications for the overall Dy-
namic Registry sample and for patient subgroups. The 95%
confidence bounds (CBs) around the expected procedural
complication rate were calculated with the normal approx-
imation to a binomial distribution. Logistic regression was
used to model the calculated risk score and major procedural
complications for the overall sample and specific subgroups.
Each model’s goodness-of-fit was assessed using the
Hosmer-Lemeshow method (12). Model discrimination
was assessed using the area under the receiver operating
curve (ROC) or the c statistic. Observed versus expected
major procedural complications by rank-ordered deciles of
risk were plotted. Logistic regression was also used to model
predictors of major procedural complications specific to the
Dynamic Registry. Baseline demographic data, patient
characteristics, and angiographic and procedural variables
were screened univariately, using a level of significance of
0.15. Standard stepwise procedures were then used to select
Abbreviations and Acronyms
CABG  coronary artery bypass graft surgery
CB  confidence bound
CHF  congestive heart failure
MI  myocardial infarction
NHLBI  National Heart, Lung, and Blood Institute
NYHA  New York Heart Association
PCI  percutaneous coronary intervention
ROC  receiver operating curve
Table 1. Mayo Clinic Risk Score: Multivariate Predictors of Procedural Complication After
Percutaneous Coronary Intervention
Variable
Integer
Score
Model
Coefficient*
Odds
Estimate 95% CI p Value
Cardiogenic shock 5 1.599 4.95 3.4–7.2 0.001
Left main coronary artery disease 5 1.467 4.34 2.5–7.6 0.001
Serum creatinine 265 mol/l† 3 0.881 2.41 1.4–4.2 0.001
Urgent or emergent procedure 2 0.758 2.13 1.5–3.1 0.001
NHYA class III 2 0.745 2.11 1.4–3.1 0.001
Thrombus 2 0.644 1.90 1.4–2.6 0.001
Multi-vessel disease 2 0.618 1.86 1.3–2.6 0.001
Age, no. of decades after 30 years 1 0.313 1.37 1.2–1.6 0.001
Intercept n/a 5.965 n/a n/a n/a
*Model 28 293.3, p 0.001. Mean value SD for bootstrap receiver operating characteristic areas: 0.782 0.018. †3 mg/dl.
CI  confidence interval; n/a  not applicable; NYHA  New York Heart Association.
1723JACC Vol. 42, No. 10, 2003 Singh et al.
November 19, 2003:1722–8 Risk Score for Percutaneous Intervention
variables to include in the final multivariable model. A
two-tailed p value 0.05 was considered significant.
RESULTS
In the Dynamic Registry, there were 96 procedural compli-
cations (2.94%) among the 3,264 patients undergoing PCI.
The majority of patients experienced a single procedural
event (53 deaths, 7 Q-wave MIs, 6 strokes, 13 urgent
CABG operations, and 11 emergent CABG operations),
although six patients experienced combined outcomes (1
urgent CABG/death, 1 emergent CABG/death, 3 Q-wave
MIs/death, and 1 stroke/death).
Demographic, clinical, and procedural characteristics.
The mean age of the patients was 62.5  11.9 years (data
not shown); 36.5% were female; 42.1% presented with
unstable angina (data not shown); and 27.1% presented with
acute MI (Table 2). At the time of the procedure, 2.3% of
patients were in cardiogenic shock. The prevalence of
hypertension was 59.2% (data not shown); 26.4% presented
with diabetes; 6.1% had peripheral vascular disease; and
3.9% reported a history of chronic kidney disease or end-
stage renal disease.
Univariate associations between baseline demographic
characteristics and major adverse complications are also
shown in Table 2. The factors significantly associated with
procedural complications included older age, lower body
mass index, acute MI, cardiogenic shock, urgent or emer-
gent procedures, diabetes, CHF on presentation, low left
ventricular ejection fraction (40%), and prevalent con-
comitant pulmonary, peripheral vascular, or renal disease.
Angiographic characteristics. High-risk angiographic
characteristics were frequently present among the study
patients, including thrombus, multi-vessel coronary artery
disease, and American College of Cardiology/American
Heart Association (ACC/AHA) type C lesions (Table 3).
Major procedural complications after PCI were significantly
associated with the presence of two- or three-vessel coro-
nary disease, total occlusion(s), lesion(s) containing intra-
coronary thrombus or calcification, ACC/AHA type C
lesion, and four or more significant lesions (vs. one signif-
icant lesion).
Validation of Mayo Clinic risk score using the NHLBI
Dynamic Registry. Using the Mayo Clinic risk score, the
observed and predicted in-hospital complications rates after
PCI in the Dynamic Registry are shown in Table 4. Overall,
there were 96 complications (2.94%) among the 3,264
patients studied. Using the coefficients from the Mayo
Clinic risk score’s logistic regression model (Table 1), 93.5
procedural complications (2.86%) were predicted (95% CB
2.32% to 3.41%; p  NS). The area under the ROC was
0.76, which indicates a good ability to discriminate between
patients who had complications during the index hospital-
ization and those who did not. The data did not deviate
significantly from the logistic model, as indicated by the
non-significant Hosmer-Lemeshow goodness-of-fit test (p
 0.28).
Selected subgroups. The discriminatory ability of the pre-
diction equation, as measured by the area under the ROC (c
statistic), was reasonably consistent across most subgroups
(0.61 to 0.81) (Table 4). The model performed slightly
worse for patients who had elective procedures (c  0.61).
However, the model performed especially well for older
patients (c 0.81) and for patients with diabetes (c 0.81).
Furthermore, the observed incident rates of procedural
complications fell within the 95% CB (null hypothesis) for
all subgroups, with the exception of patients who presented
with a previous CABG. In this instance, the model signif-
icantly overpredicted the number of procedural complica-
tions. With the exception of patients undergoing urgent or
emergent PCI, the non-significant Hosmer-Lemeshow
goodness-of-fit p values indicated little departure in model
fit.
Integer risk score. Based of the integer portion of the risk
score, each patient was categorized into one of five post-PCI
procedural complication risk groups. Among the Dynamic
Registry patients, 1,669 (51.1%) were considered very low
risk, 1,089 (33.4%) as low risk, 351 (10.8%) as moderate
risk, 102 (3.1%) as high risk, and 53 (1.6%) as very high risk.
The observed rates of procedural complications (and the
expected range of events based on the Mayo Clinic data) in
these strata were as follows: 1.26% (2%) for very low-risk
procedures, 1.93% (2% to 5%) for low-risk procedures,
6.84% (5% to 10%) for moderate-risk procedures, 8.82%
(10% to 25%) for high-risk procedures, and 39.6%
(25%) for very high-risk procedures (Fig. 1). These data
demonstrate an overall linear relationship between risk
strata and the incidence of procedural complications, with
exceptionally high relative risk among patients categorized
as very high risk of PCI complications.
Predictors of major procedural complications in the
Dynamic Registry. A multivariate model of predictors of
major in-hospital outcomes specific to the Dynamic Regis-
try included the following variables: older age, CHF during
index hospitalization, cardiogenic shock, total occlusion
attempted, the number of attempted lesions, urgent or
emergent procedure, and the presence of severe concomitant
renal disease (Table 5). Although there are some differences,
mainly involving angiographic variables, many of the same
variables are included in both the Dynamic Registry and
Mayo Clinic models (Table 1) for procedural complications.
The non-significant Hosmer-Lemeshow goodness-of-fit p
value indicated that the model was adequate.
DISCUSSION
In this report, we assessed the validity of the Mayo Clinic
risk score for the prediction of procedural complications
after PCI by using an external data set. Using the Dynamic
Registry, we found essentially no difference between the
observed procedural complication rate and predicted com-
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Table 2. Univariate Association of Patient Demographic and Cardiac Risk Factors With Major
Procedural Complications in the NHLBI Dynamic Registry
Factor
Patients
(%)
Procedural
Complications (%)
Odds
Ratio 95% CI p Value
Age (yrs)
60 42.3 2.0 1.0 Ref.
60–69 28.7 2.7 1.37 0.79–2.38 0.25
70–79 22.2 4.3 2.25 1.33–3.80 0.002
80 6.9 5.8 3.09 1.57–6.08 0.001
Gender
Male 63.5 2.7 1.0 Ref.
Female 36.5 3.4 1.25 0.83–1.89 0.29
Race
White 78.2 3.3 1.0 Ref.
Non-white 21.8 1.7 0.50 0.27–0.93 0.03
BMI (kg/m2)
24.9 24.9 3.8 1.0 Ref.
24.9 to 29.9 44.2 3.1 0.81 0.51–1.29 0.38
29.9 30.9 1.8 0.46 0.25–0.83 0.008
Previous CABG
No 87.4 3.0 1.0 Ref.
Yes 12.6 2.4 0.80 0.4–1.56 0.51
Acute MI
No 72.9 1.8 1.0 Ref.
Yes 27.1 6.1 3.61 2.40–5.45 0.001
Cardiogenic shock
No 97.7 2.2 1.0 Ref.
Yes 2.3 33.3 21.96 12.86–37.48 0.001
Acuity
Elective 59.4 1.4 1.0 Ref.
Urgent 27.4 2.5 1.78 1.01–3.15 0.04
Emergent 13.2 11.0 8.70 5.35–14.14 0.001
Angina*
Stable 34.3 1.1 1.0 Ref.
Unstable 65.7 2.0 1.85 0.84–4.07 0.12
Diabetes
No 73.6 2.3 1.0 Ref.
Yes 26.4 4.0 1.75 1.13–2.71 0.01
Current smoker
No 70.8 2.8 1.0 Ref.
Yes 29.2 2.3 0.84 0.51–1.40 0.51
History of hypercholesterolemia
No 42.4 3.0 1.0 Ref.
Yes 57.6 2.0 0.65 0.41–1.04 0.07
Current CHF
No 72.2 2.1 1.0 Ref.
Yes 7.8 13.3 7.31 4.71–11.35 0.001
Left ventricular ejection fraction†
40% 87.9 1.6 1.0 Ref.
40% 12.1 8.3 5.76 3.18–10.44 0.001
Pulmonary disease
No 92.4 2.6 1.0 Ref.
Yes 7.6 4.9 1.92 1.03–3.58 0.04
PVD
No 93.9 2.6 1.0 Ref.
Yes 6.1 5.1 1.97 1.01–3.87 0.04
Renal disease
No 96.1 2.7 1.0 Ref.
Yes 3.9 9.5 3.79 2.01–7.14 0.001
*Excludes all patients whose reason for revascularization was something other than stable or unstable angina (n  1,175). †Data
were missing on 1,277 patients.
BMI  body mass index; CABG  coronary artery bypass graft; CHF  congestive heart failure; CI  confidence interval;
MI  myocardial infarction; PVD  peripheral vascular disease; Ref.  reference value.
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plications based on the Mayo Clinic risk model. There was
no departure in model fit, and model discrimination was
high. Furthermore, observed and predicted complication
rates among most low- and high-risk subgroups were
generally similar, suggesting that the Mayo Clinic risk score
applies well across most patient subgroups. Thus, our results
indicate that readily available clinical and angiographic
variables—those used in the Mayo Clinic risk score, in
particular—can be used for patient risk stratification at the
time of initial presentation.
Previous studies with validation of predictors of compli-
cations. Previously published studies on predictors (e.g.,
risk function) of complications after PCI have had meth-
odologic limitations. Many included in-hospital mortality
only and were based on internally validated samples
(8,9,13,14), using the same data set in a different year or
derived from the same consortium. Moreover, in some
studies, important procedural and angiographic variables
that improve the discriminatory accuracy of the risk score
have been lacking (7,8,13). The recent score from the
Table 3. Univariate Association of Angiographic Risk Factors With Major Procedural
Complications in the NHLBI Dynamic Registry
Factor
Patients
(%)
Procedural
Complications (%)
Odds
Ratio 95% CI p Value
Vessel disease
Single 44.5 2.1 1.0 Ref.
Double 32.7 3.4 1.66 1.02–2.71 0.04
Triple 22.8 3.9 1.93 1.15–3.24 0.01
LAD disease
No 30.7 2.9 1.0 Ref.
Yes 69.3 3.0 1.02 0.66–1.59 0.92
Any total occlusion
No 64.0 1.7 1.0 Ref.
Yes 36.0 5.2 3.21 2.10–4.89 0.001
Attempted thrombotic lesion
No 72.1 1.9 1.0 Ref.
Yes 27.9 5.5 2.92 1.94–4.38 0.001
Attempted calcified lesion
No 69.4 2.3 1.0 Ref.
Yes 30.6 4.4 1.96 1.31–2.96 0.001
Attempted class C lesion
No 79.0 2.4 1.0 Ref.
Yes 21.0 5.0 2.13 1.39–3.26 0.001
No. of significant lesions
1 31.9 2.1 1.0 Ref.
2 26.4 2.3 1.10 0.60–2.03 0.76
3 17.1 3.4 1.63 0.88–3.04 0.12
4 24.7 4.4 2.10 1.22–3.61 0.006
CI  confidence interval; LAD  left anterior descending coronary artery; Ref.  reference value.
Table 4. Observed and Predicted Procedural Failures and Model Evaluation Criteria Among All NHLBI-Dynamic Registry Patients
and by Baseline Demographic and Procedural Subgroups
Subgroup
Procedural Failures No.
ROC Area p Value*n No. Observed (%) No. Predicted (%) 95% CB
Overall 3,264 96 (2.94) 93.5 (2.86) 2.32–3.41% 0.76 0.28
Age (yrs)
65 1,836 36 (1.96) 33.8 (1.84) 1.24–2.44% 0.66 0.61
65 1,428 60 (4.20) 59.7 (4.18) 3.20–5.16% 0.81 0.18
Gender
Female 1,192 40 (3.36) 35.8 (3.00) 2.07–3.93% 0.81 0.72
Male 2,072 56 (2.70) 57.7 (2.78) 2.11–3.45% 0.72 0.41
Acuity
Urgent or emergent 1,324 69 (5.21) 63.9 (4.83) 3.74–5.91% 0.78 0.05
Elective 1,940 27 (1.39) 29.6 (1.53) 0.98–2.06% 0.61 0.34
In-hospital CHF 255 34 (13.33) 25.7 (10.1) 6.67–13.49% 0.65 0.13
Previous CABG 411 10 (2.43) 20.0 (4.87) 2.87–6.86% 0.70 0.64
Diabetes 851 34 (3.99) 31.9 (3.75) 2.55–4.95% 0.81 0.82
*Hosmer-Lemeshow goodness-of-fit. A non-significant p value (0.05) indicates good model fit.
CB  confidence bound; ROC  receiver operating curve; other abbreviations as in Table 2.
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Michigan Cardiovascular Consortium identified several
clinical and angiographic variables that overlap with the
Mayo Clinic score; however, an independent validation data
set was obtained from the same consortium from which the
initial model was developed, limiting its broader applicabil-
ity (8). Kimmel et al. (13) identified major predictors of
complications from prospectively collected data for the
Society for Cardiac Angiography and Interventions for the
year 1992, which were validated in patients undergoing PCI
in 1993. Importantly, since the development of this model,
interventional cardiology has changed, with widespread use
of stents and glycoprotein IIb/IIIa inhibitors. The New
York State percutaneous transluminal coronary angioplasty
mortality model was applied to patients undergoing stent
implantation at the Mayo Clinic, with excellent prediction
of in-hospital and late mortality (7). However, this model
did not include any specific lesion characteristics that might
influence the prediction of in-hospital mortality.
The present study. There are several strengths of the
present study that address the limitations noted in the
previous paragraph. First, our risk score has been validated
and predicts not only mortality but also important adverse
cardiovascular events, including stroke, MI, and the need
for urgent/emergent CABG. Including these events is
equally important in decision-making, as they increase a
patient’s morbidity and length of stay in the hospital.
Second, our model was tested and validated in an indepen-
dent data set. Third, patients in both the data sets were
treated with a contemporary interventional stent-based
approach relevant to current practice. Fourth, the Mayo
Clinic risk score demonstrated consistency in predicting
patient risk across many subgroups and levels of overall risk.
Finally, the variables that were identified from the NHLBI
Dynamic Registry significantly overlapped with the Mayo
Clinic risk score, with the exception of some angiographic
features, adding credence to this score.
Study limitations. The issue of the applicability of the
Mayo Clinic model to non-referral, low-volume centers and
to low-volume interventionists cannot be evaluated from the
present study. In the Dynamic Registry, the overall event
rates were low, and there were few high-risk patients. There
was also an indication that the Mayo Clinic risk model did
not perform optimally at the extremes (high- and low-risk
patients), with significant overprediction of procedural com-
plications in patients with a previous CABG. The subop-
timal fit among low-risk subgroups most likely stems from
the inclusion of high-risk variables such as cardiogenic
shock, left main coronary disease, and CHF. Operator
volume, a variable not addressed in the current study, has
also been found to be significantly associated with adverse
events after PCI (15–19). This variable was not addressed in
Figure 1. Observed major procedural complication rate by integer score categories in the NHLBI Dynamic Registry. The integers are proportional to the
estimated continuous coefficient from the Mayo Clinic risk score logistic model. The values from the integer risk score were categorized as follows: very
low risk (0 to 5), low risk (6 to 8), moderate risk (9 to 11), high risk (12 to 14), and very high risk (15). There was a linear association between incident
procedural events and integer risk score categories (test for trend p  0.001).
Table 5. Multivariate Predictors of Major Procedural
Complications After Percutaneous Coronary Intervention in the
NHLBI Dynamic Registry
Variable
Model
Coefficient
Odds
Ratio 95% CI p Value
Age (yrs) 0.026 1.03 1.01–1.05 0.007
Current CHF 1.182 3.26 1.93–5.50 0.001
Cardiogenic shock 1.891 6.62 3.44–12.74 0.001
Total occlusion attempted 1.127 3.09 1.93–4.94 0.001
No. of attempted lesions* 0.353 1.42 1.08–1.87 0.01
Urgent or emergent procedure 0.731 2.08 1.26–3.42 0.004
Chronic kidney disease 1.231 3.43 1.69–6.92 0.001
Intercept 6.945 n/a n/a n/a
*Number of attempted lesions categorized as 1, 2, 3, or 4. Hosmer-Lemeshow
goodness-of-fit 28  10.06, p  0.26. A non-significant p value (0.05) indicates
good model fit. Area under the receiver operating curve  0.82.
CHF  congestive heart failure; CI  confidence interval; n/a  not applicable.
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the present study. Due to differences in definitions across
studies, it is possible that the calculated probabilities of
procedural complication may be inflated in the Dynamic
Registry. Misclassification may have occurred with respect
to renal, multi-vessel, and left main coronary disease vari-
ables. Finally, though the Mayo Clinic risk score was
accurate in predicting procedural complications, no predic-
tive model can ameliorate the effect of chance and unantic-
ipated circumstances and complications inherently encoun-
tered in invasive treatments.
Conclusions. External validation of the Mayo Clinic risk
score using the multi-center NHLBI Dynamic Registry
study confirms the broader applicability of this score in
predicting in-hospital complications, defined as either
death, Q-wave MI, emergent or urgent CABG, or cerebro-
vascular accidents, using eight simple clinical and angio-
graphic variables. Most of the variables can be obtained at
the time of first contact with the patient. Risk stratification
may help the operator to individualize the risk of procedural
complications from PCI and to counsel patients at the time
of PCI.
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